Lytix Biopharma is a clinical-stage immuno-oncology company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer.
Lead compound LTX-315 provides access to antigens by using the patient’s own tumor as source of antigens and turns cold tumors hot.
Local treatment with LTX-315 targets the first step in the cancer immunity cycle with a potential cornerstone position in immunotherapy.
Company Details
- Employees
- 23
- Founded
- -
- Address
- Sandakerveien 138, Oslo,0484,norway
- Phone
- +47 77 67 55 00
- po****@****rma.com
- Industry
- Biotechnology
- Website
- lytixbiopharma.com
- Keywords
- across Europe and Asia..
- HQ
- Oslo
Lytix Biopharma Questions
Lytix Biopharma's helpline number is +47 77 67 55 00
Lytix Biopharma's website is lytixbiopharma.com
Lytix Biopharma's LinkedIn profile is https://no.linkedin.com/company/lytix-biopharma
Lytix Biopharma has
23 employees.
View email and phone details for 23
employees at Lytix Biopharma.
Lytix Biopharma's industry is
Biotechnology
Lytix Biopharma's top competitors are
Ultimovacs Asa,
Circio Holding Asa,
Bergenbio Asa,
Verrica Pharmaceuticals,
Curida Diatec,
Thor Medical Asa,
Oncoinvent Asa,
Zelluna,
Nykode Therapeutics,
Ilya Pharma.
Lytix Biopharma's support email address is post@lytixbiopharma.com
Lytix Biopharma's categories are Biotechnology
Lytix Biopharma's founding year is 2003
